Clinical Trial Update: Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency Department [Phase 4]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 4 study evaluating nesiritide infusion for decompensated heart failure in the emergency department.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Heart Failure

Drugs mentioned

• Nesiritide (Natrecor) (nesiritide)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Heart Failure, Congestive, Cardiomyopathy | Phase 4 | Status: COMPLETED